Ginkgo Bioworks (DNA)

• Market cap: $428M
• 1 day: -0.14%
• 5 days: -4.04%
• 1 month: 29.30%
• 3 months: -47.02%
• 6 months: -5.99%
• Year to date: -27.89%
• 1 year: -79.32%
• 5 years: -98.49%
• 10 years: -98.49%
• Sector: Healthcare
• Industry: Biotechnology

About: Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Employees: 834

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

290% more call options, than puts

Call options by funds: $29.6M | Put options by funds: $7.59M

50% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 3 (+1) [Q4]

49% more capital invested

Capital invested by funds: $214M [Q3] → $319M (+$104M) [Q4]

38% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 26

10.83% more ownership

Funds ownership: 61.09% [Q3] → 71.92% (+10.83%) [Q4]

5% more funds holding

Funds holding: 158 [Q3] → 166 (+8) [Q4]

8% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 39